These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 27664806)
1. BubR1 Insufficiency Results in Decreased Macrophage Proliferation and Attenuated Atherogenesis in Apolipoprotein E-Deficient Mice. Tanaka S; Matsumoto T; Matsubara Y; Harada Y; Kyuragi R; Koga JI; Egashira K; Nakashima Y; Yonemitsu Y; Maehara Y J Am Heart Assoc; 2016 Sep; 5(9):. PubMed ID: 27664806 [TBL] [Abstract][Full Text] [Related]
2. BubR1 insufficiency inhibits neointimal hyperplasia through impaired vascular smooth muscle cell proliferation in mice. Kyuragi R; Matsumoto T; Harada Y; Saito S; Onimaru M; Nakatsu Y; Tsuzuki T; Nomura M; Yonemitsu Y; Maehara Y Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):341-7. PubMed ID: 25524773 [TBL] [Abstract][Full Text] [Related]
3. Repopulation of apolipoprotein E knockout mice with CCR2-deficient bone marrow progenitor cells does not inhibit ongoing atherosclerotic lesion development. Guo J; de Waard V; Van Eck M; Hildebrand RB; van Wanrooij EJ; Kuiper J; Maeda N; Benson GM; Groot PH; Van Berkel TJ Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1014-9. PubMed ID: 15774908 [TBL] [Abstract][Full Text] [Related]
4. Nrf2 in bone marrow-derived cells positively contributes to the advanced stage of atherosclerotic plaque formation. Harada N; Ito K; Hosoya T; Mimura J; Maruyama A; Noguchi N; Yagami K; Morito N; Takahashi S; Maher JM; Yamamoto M; Itoh K Free Radic Biol Med; 2012 Dec; 53(12):2256-62. PubMed ID: 23051009 [TBL] [Abstract][Full Text] [Related]
5. Macrophage-derived apolipoprotein E ameliorates dyslipidemia and atherosclerosis in obese apolipoprotein E-deficient mice. Atkinson RD; Coenen KR; Plummer MR; Gruen ML; Hasty AH Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E284-90. PubMed ID: 18029445 [TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein CI aggravates atherosclerosis development in ApoE-knockout mice despite mediating cholesterol efflux from macrophages. Westerterp M; Van Eck M; de Haan W; Offerman EH; Van Berkel TJ; Havekes LM; Rensen PC Atherosclerosis; 2007 Nov; 195(1):e9-16. PubMed ID: 17320883 [TBL] [Abstract][Full Text] [Related]
7. TSLPR deficiency attenuates atherosclerotic lesion development associated with the inhibition of TH17 cells and the promotion of regulator T cells in ApoE-deficient mice. Wu C; He S; Peng Y; Kushwaha KK; Lin J; Dong J; Wang B; Lin J; Shan S; Liu J; Huang K; Li D J Mol Cell Cardiol; 2014 Nov; 76():33-45. PubMed ID: 25117469 [TBL] [Abstract][Full Text] [Related]
8. Angiotensin II amplifies macrophage-driven atherosclerosis. Nobuhiko A; Suganuma E; Babaev VR; Fogo A; Swift LL; Linton MF; Fazio S; Ichikawa I; Kon V Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2143-8. PubMed ID: 15374850 [TBL] [Abstract][Full Text] [Related]
9. BubR1 Insufficiency Impairs Liver Regeneration in Aged Mice after Hepatectomy through Intercalated Disc Abnormality. Ikawa-Yoshida A; Matsumoto T; Okano S; Aoyagi Y; Matsubara Y; Furuyama T; Nakatsu Y; Tsuzuki T; Onimaru M; Ohkusa T; Nomura M; Maehara Y Sci Rep; 2016 Aug; 6():32399. PubMed ID: 27561386 [TBL] [Abstract][Full Text] [Related]
10. Protection of atherogenesis in thromboxane A2 receptor-deficient mice is not associated with thromboxane A2 receptor in bone marrow-derived cells. Zhuge X; Arai H; Xu Y; Murayama T; Kobayashi T; Narumiya S; Kita T; Yokode M Biochem Biophys Res Commun; 2006 Dec; 351(4):865-71. PubMed ID: 17097058 [TBL] [Abstract][Full Text] [Related]
11. Deletion of bone marrow-derived receptor for advanced glycation end products inhibits atherosclerotic plaque progression. Morris-Rosenfeld S; Blessing E; Preusch MR; Albrecht C; Bierhaus A; Andrassy M; Nawroth PP; Rosenfeld ME; Katus HA; Bea F Eur J Clin Invest; 2011 Nov; 41(11):1164-71. PubMed ID: 21418204 [TBL] [Abstract][Full Text] [Related]
12. Effect of macrophage-derived apolipoprotein E on hyperlipidemia and atherosclerosis of LDLR-deficient mice. Shi W; Wang X; Wong J; Hedrick CC; Wong H; Castellani LW; Lusis AJ Biochem Biophys Res Commun; 2004 Apr; 317(1):223-9. PubMed ID: 15047172 [TBL] [Abstract][Full Text] [Related]
13. Discoidin domain receptor 1 on bone marrow-derived cells promotes macrophage accumulation during atherogenesis. Franco C; Britto K; Wong E; Hou G; Zhu SN; Chen M; Cybulsky MI; Bendeck MP Circ Res; 2009 Nov; 105(11):1141-8. PubMed ID: 19834008 [TBL] [Abstract][Full Text] [Related]
14. CD44 expressed on both bone marrow-derived and non-bone marrow-derived cells promotes atherogenesis in ApoE-deficient mice. Zhao L; Lee E; Zukas AM; Middleton MK; Kinder M; Acharya PS; Hall JA; Rader DJ; Puré E Arterioscler Thromb Vasc Biol; 2008 Jul; 28(7):1283-9. PubMed ID: 18420998 [TBL] [Abstract][Full Text] [Related]
15. Reduced atherosclerotic lesions in P2Y1/apolipoprotein E double-knockout mice: the contribution of non-hematopoietic-derived P2Y1 receptors. Hechler B; Freund M; Ravanat C; Magnenat S; Cazenave JP; Gachet C Circulation; 2008 Aug; 118(7):754-63. PubMed ID: 18663083 [TBL] [Abstract][Full Text] [Related]
16. Perilipin1 deficiency in whole body or bone marrow-derived cells attenuates lesions in atherosclerosis-prone mice. Zhao X; Gao M; He J; Zou L; Lyu Y; Zhang L; Geng B; Liu G; Xu G PLoS One; 2015; 10(4):e0123738. PubMed ID: 25855981 [TBL] [Abstract][Full Text] [Related]